Nucmito Pharmaceuticals Co. Ltd. has disclosed indene derivatives reported to be useful for the treatment of cancer and fibrosis.

Sun Yat-Sen University has divulged pyrimidodiazepanone compounds reported to be useful for the treatment of depression.

Jiangsu Chia Tai Tianqing Pharmaceutical Group Co. Ltd. has presented solute carrier family 22 member 12 (SLC22A12) inhibitors reported to be useful for the treatment of gout and hyperuricemia.

Drugs for Neglected Diseases Initiative has described pyrrolopirimidine derivatives reported to be useful for the treatment of leishmaniasis.

Chengdu Baiyu Pharmaceutical Co. Ltd. has identified piperazine derivatives acting as protein mono-ADP-ribosyltransferase TIPARP inhibitors reported to be useful for the treatment of cancer.

Aurigene Discovery Technologies Ltd. has divulged fused isoxazolyl compounds acting as histone acetyltransferase KAT6A (monocytic leukemia zinc finger protein; MOZ; MYST-3) inhibitors reported to be useful for the treatment of cancer.

Jing Medicine Technology (Shanghai) Ltd. has patented proteolysis targeting chimera (PROTACs) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to ALK tyrosine kinase receptor- and/or epidermal growth factor receptor (EGFR)- and/or proto-oncogene tyrosine-protein kinase ROS (ROS1)-targeting moiety reported to be useful for the treatment of cancer.

CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd. has patented spiro compounds acting as tyrosine-protein phosphatase nonreceptor type 11 (PTPN11) inhibitors reported to be useful for the treatment of cancer and cardiovascular and immunological disorders.

Sironax Ltd. has disclosed receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors reported to be useful for the treatment of ulcerative colitis, Crohn's disease, psoriasis, rheumatoid arthritis, amyotrophic lateral sclerosis (ALS), Alzheimer's disease and viral infection.

Gilead Sciences Inc. has presented pentacyclic derivative compounds reported to be useful for the treatment of Zika virus infection.